These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9418131)

  • 1. The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding.
    Huard R; Dyall R; Nikolić-Zugić J
    Int Immunol; 1997 Nov; 9(11):1701-7. PubMed ID: 9418131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.
    Fremont DH; Stura EA; Matsumura M; Peterson PA; Wilson IA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2479-83. PubMed ID: 7708669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers.
    McFarland BJ; Sant AJ; Lybrand TP; Beeson C
    Biochemistry; 1999 Dec; 38(50):16663-70. PubMed ID: 10600129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.
    Dyall R; Fremont DH; Jameson SC; Nikolić-Zugić J
    J Exp Med; 1996 Jul; 184(1):253-8. PubMed ID: 8691139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging principles for the recognition of peptide antigens by MHC class I molecules.
    Matsumura M; Fremont DH; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
    Ma H; Kapp JA
    Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
    Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
    J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide binding to MHC class I is determined by individual pockets in the binding groove.
    Johansen TE; McCullough K; Catipovic B; Su XM; Amzel M; Schneck JP
    Scand J Immunol; 1997 Aug; 46(2):137-46. PubMed ID: 9583994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.
    Li H; Natarajan K; Malchiodi EL; Margulies DH; Mariuzza RA
    J Mol Biol; 1998; 283(1):179-91. PubMed ID: 9761682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
    Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
    Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identities of P2 and P3 Residues of H-2Kb-Bound Peptides Determine Mouse Ly49C Recognition.
    Marquez EA; Kane KP
    PLoS One; 2015; 10(7):e0131308. PubMed ID: 26147851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
    Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
    Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
    Mo AX; van Lelyveld SF; Craiu A; Rock KL
    J Immunol; 2000 Apr; 164(8):4003-10. PubMed ID: 10754291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
    Chen W; Khilko S; Fecondo J; Margulies DH; McCluskey J
    J Exp Med; 1994 Oct; 180(4):1471-83. PubMed ID: 7523572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The H-2Kk MHC peptide-binding groove anchors the backbone of an octameric antigenic peptide in an unprecedented mode.
    Kellenberger C; Roussel A; Malissen B
    J Immunol; 2005 Sep; 175(6):3819-25. PubMed ID: 16148128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of hen egg lysozyme HEL[52-61] peptide binding to I-Ak MHC class II molecule.
    Weber P; Raynaud I; Ettouati L; Trescol-Biémont MC; Carrupt PA; Paris J; Rabourdin-Combe C; Gerlier D; Testa B
    Int Immunol; 1998 Dec; 10(12):1753-64. PubMed ID: 9885896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of non-anchor residues of Db-restricted peptides in class I binding and TCR triggering.
    Sigal LJ; Wylie DE
    Mol Immunol; 1996 Dec; 33(17-18):1323-33. PubMed ID: 9171892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.